MEITAV INVESTMENT HOUSE LTD - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$13,000
-78.3%
61,362
-51.7%
0.00%
-75.0%
Q2 2019$60,000
+9.1%
127,0640.0%0.00%
+33.3%
Q1 2019$55,000
+41.0%
127,064
+0.0%
0.00%
+50.0%
Q4 2018$39,000
-57.1%
127,062
-0.0%
0.00%
-50.0%
Q3 2018$91,000
+225.0%
127,064
+107.1%
0.00%
+300.0%
Q2 2018$28,000
-58.8%
61,364
-51.7%
0.00%
-66.7%
Q1 2018$68,000
-20.0%
127,0620.0%0.00%
-40.0%
Q4 2017$85,000127,0620.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders